Healthcare Services

Fibromyalgia Treatment Market Growth Supported by Rising Aging Population

April 21, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

From Its 2026 Market Size, What Value Is The Fibromyalgia Treatment Market Projected To Reach By 2030?

The fibromyalgia treatment market size has experienced consistent expansion in recent years. It is anticipated to increase from $2.89 billion in 2025 to $3.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 4.2%. The historical development of this market is attributable to a greater diagnosis of chronic pain disorders, the availability of antidepressants and antiepileptics, improved access to healthcare, the proliferation of pain clinics, and enhanced awareness of the disease.

The fibromyalgia treatment market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $3.67 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.0%. Factors driving this expansion during the projection period encompass advancements in targeted pain therapies, an increase in personalized treatment strategies, greater integration of digital tools for pain management, the proliferation of integrative therapies, and heightened awareness regarding mental health. Prominent trends expected over the forecast horizon involve the increasing utilization of symptom-focused drug treatments, a wider acceptance of multimodal therapeutic strategies, an intensified emphasis on managing chronic pain, the growth of non-pharmacological interventions, and enhanced patient-centric care models.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

Which Factors Are Influencing The Growth Of The Fibromyalgia Treatment Market?

An increasing elderly demographic is anticipated to fuel the expansion of the fibromyalgia treatment market. This demographic trend describes a growing percentage of older people in a community or general populace. Fibromyalgia interventions prove especially beneficial for older demographics, as seniors are more prone to developing the condition and frequently suffer from harsher symptoms influenced by age-related factors. For example, in 2023, the UK-registered charity Age UK reported that England had 11 million individuals aged over 65. This number is forecast to rise by 10% over the next five years and by 32% by 2043, equating to an additional 1.1 and 3.5 million people, respectively. Furthermore, the population aged 85+, which typically requires the most health and care services, is also expected to grow quickly, with an 8.2% increase in the next five years and a 62.7% increase by 2043, representing 126,000 and 956,000 more individuals, respectively. Consequently, the expanding elderly population is a key factor driving the growth of the fibromyalgia treatment market.

How Is Segmentation Applied In The Fibromyalgia Treatment Market Segment Analysis?

The fibromyalgia treatment market covered in this report is segmented –

1) By Type: Symptomatic Treatment, Targeted Treatment

2) By Drug Class: Antidepressants, Antiepileptics, Muscle Relaxants, Analgesics, Other Drugs

3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy

Subsegments:

1) By Symptomatic Treatment: Pain Relievers, Antidepressants, Anti-seizure Medications, Sleep Aids, Physical Therapy

2) By Targeted Treatment: Cognitive Behavioral Therapy (CBT), Lifestyle Modifications, Complementary Therapies, Medications Targeting Specific Symptoms

Which Trends Are Influencing Demand In The Fibromyalgia Treatment Market?

Leading firms in the fibromyalgia treatment market are prioritizing the creation of cutting-edge solutions, including computerized behavioral therapy devices, to secure a competitive edge. Such a device represents a software-driven prescription therapy, offering structured psychological interventions like Acceptance and Commitment Therapy (ACT) through a digital medium. As an illustration, in May 2023, Swing Therapeutics, a digital therapeutics company based in the U.S., obtained FDA De Novo authorization for Stanza. This prescription smartphone-based digital therapy provides a 12-week self-guided ACT program, which showed notable enhancements in pain, fatigue, sleep, and mood during its crucial PROSPER-FM Phase 3 trial. Stanza is accessible through Swing Care, a virtual specialty clinic that combines prescription digital therapy with thorough fibromyalgia management strategies. This development improves patient accessibility, lessens dependence on pharmacological treatments, and aligns with non-drug care guided by established guidelines, although hurdles persist concerning the expansion of reimbursement and adoption by clinicians.

Who Are The Companies Participating In The Fibromyalgia Treatment Market Environment?

Major companies operating in the fibromyalgia treatment market are Pfizer Inc., Johnson and Johnson Services Inc., AbbVie Inc., Eli Lilly and Company, Amgen Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Biogen Inc., Daiichi Sankyo Co. Ltd., Sun Pharmaceutical Industries Ltd., Horizon Therapeutics plc, Endo International plc, Amneal Pharmaceuticals Inc., Zydus Lifesciences Limited, Lupin Limited, Tonix Pharmaceuticals, Allergan plc, Aptinyx Inc., Novartis AG, Merck & Co Inc.

Get The Full Fibromyalgia Treatment Market Report:

https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

Which Region Is The Top Contributor To The Fibromyalgia Treatment Market By Share?

North America was the largest region in the fibromyalgia market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the fibromyalgia treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Fibromyalgia Treatment Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/fibromyalgia-treatment-global-market-report

Browse Through More Reports Similar to the Global Fibromyalgia Treatment Market 2026, By The Business Research Company

Neurofibromatosis Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurofibromatosis-treatment-global-market-report

Neuralgia Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/neuralgia-treatment-global-market-report

Muscle Pain Treatment Market Report 2026

https://www.thebusinessresearchcompany.com/report/muscle-pain-treatment-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795